What could strengthen or challenge D. R. Horton’s outlook?
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Higher potential upsideImproving expectations
Next-FY EPS estimate change · 30 days
Comparable estimates unavailable
+10% or more+5%0%−5%−10% or less
A matching fiscal period and sufficient coverage are required.
Higher risk of downsideWeakening expectations
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
How this is measured
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living FV™
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 3 of last 3 quarters. Management reiterated a dividend payment target of approximately $500 million for fiscal 2026. Actual dividends paid through 2026-Q3 were $388.3 million. The trajectory is consistent with the stated target.
Delivery assessment Oct 15, 2026
Manage impact of macroeconomic headwinds on revenue growth
A primary condition in D. R. Horton's published investment case. The stated target is Revenue growth remains near 6% despite macro challenges.
Under Pressure
Revenue growth falls below 6% next year due to macro factors
Direct metric needs a verified mapping
The published measure or accounting basis is not supported by an exact source binding.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 3 of last 3 quarters. Management reiterated a $2.5 billion share repurchase target for fiscal 2026. Actual repurchases through 2026-Q3 totaled $2.2 billion. The trajectory is delivering close to the stated target.
Delivery assessment Oct 15, 2026
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Incoming Evidence
Compare these dated observations with the operating requirements above
Expectations trend
Same fiscal period
FY2028 · fiscal year ending 2028-09-30 · fmp
FY2028 EPS$13.32
$13.54 → $13.32 · observed estimates
FY2028 revenue$35.94B
$36.86B → $35.94B · observed estimates
Exact estimates & source dates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
FY2028 estimate observations · fmp
Snapshot
EPS
Revenue
EPS / revenue analysts
2026-10-01
$13.54
$36,858,254,259
6 / 6
2026-10-02
$13.54
$36,858,254,259
6 / 6
2026-10-03
$13.50
$36,487,957,264
6 / 7
2026-10-04
$13.50
$36,487,957,264
6 / 7
2026-10-05
$13.50
$36,487,957,264
6 / 7
2026-10-06
$13.50
$36,487,957,264
6 / 7
2026-10-07
$13.42
$36,196,591,941
6 / 7
2026-10-08
$13.40
$36,372,128,514
6 / 7
2026-10-09
$13.40
$36,372,128,514
7 / 8
2026-10-10
$13.40
$36,372,128,514
7 / 8
2026-10-11
$13.40
$36,372,128,514
7 / 8
2026-10-12
$13.40
$36,372,128,514
7 / 8
2026-10-13
$13.32
$36,190,507,014
7 / 8
2026-10-14
$13.32
$35,944,821,412
7 / 8
2026-10-15
$13.32
$35,944,821,412
7 / 8
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
0 raises · 3 cuts · 0 unchanged · 2 without a comparable prior
How this is measured
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Outlook in Brief
The evidence, the remaining questions, and what comes next
What's improving
No recovery evidence is reported in the available driver assessments.
Still unresolved / key risks
Maintain dividend payments at approximately $500 million in fiscal 2026Direct metric needs a verified mapping
Manage impact of macroeconomic headwinds on revenue growthPublished status: Under Pressure
Increase revenue to $33.5-$34.5 billion in fiscal 2026Published status: Broken
Repurchase approximately $2.5 billion of shares in fiscal 2026Required source inputs unavailable
Next proof point
Oct 29, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Risk observations as of Oct 15, 2026 · 277 daily observations. Historical moves are not forecasts.
Read detailed Outlook Company context, assumptions & risks
D. R. Horton outlook in detail
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
What kind of bet this is
This investment represents a durable compounder with a focus on steady revenue growth and shareholder returns. The current thesis state is intact, though confidence has shifted to medium due to recent performance revisions.
What's priced into D. R. Horton
The market appears to price DHI as relatively cheap compared to peers, with a slight expectations gap. However, the valuation is justified given the company's fragile earnings quality and the current sector backdrop.
What the fundamentals likely do
Management is on track to meet its revenue goals, but recent downward revisions in guidance for home closings indicate potential challenges. The near-term risk is moderate, with a low probability of missing earnings expectations.
What D. R. Horton hinges on
Key factors for DHI's performance include the potential for further guidance cuts and inflation trends that could impact consumer spending. Additionally, the performance of sector bellwethers like PHM, LEN, and NVR will be crucial for DHI's momentum.
Bottom line
Overall, DHI's outlook remains cautious as it navigates a challenging environment while aiming to meet its strategic goals. Not investment advice.
Source: QuarterlyIQ weekly Outlook · Week ending Oct 10, 2026 · Carried forward
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
